Adaptimmune Therapeutics PLC

Adaptimmune Therapeutics PLC financial statements

Adaptimmune Therapeutics PLC's income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.

FY2024

RevenueUSD 178.03M10-K
Net income−USD 70.81M10-K
Cash and equivalentsUSD 91.14M10-Q
Total debtUSD 54.28M10-K

Adaptimmune Therapeutics PLC financials on 6ix · Adaptimmune Therapeutics PLC on 6ix